As part of our studies to identify the gene responsible for hereditary gingival fibromatosis, GINGF (OMIM 135300), we have identified and cloned a novel human gene that contains the highly conserved methyltransferase domain characteristic of S-adenosylmethionine-dependent methyltransferases. We localized this gene (C2orf8 encoding 288L6 SAM-methyltransferase) to chromosome 2p22→p21 by FISH, and sublocalized it to BAC RP11 288L6 flanked by D2S2238 and D2S2331. Computational analysis of aligned ESTs identified ten exons in the hypothetical C2orf8 gene. Results of RACE analyses in placenta identified multiple transcripts of this gene with heterogeneity at the 5′-UTR. Alternative transcription and tissue specific expression of C2orf8 were detected by RT-PCR and Northern blot analyses. C2orf8 is expressed in a variety of tissues including brain, colon, gingiva, heart, kidney, liver, lung, placenta, small intestine, spleen, and thymus. Open reading frame analysis of the alternative transcripts identified a shared coding region spanning exons 6–10. This ORF consists of 732 nucleotides encoding a putative 244 amino acid protein. Bioinformational searches of both C2orf8 and the putative protein product identified three methyltransferase motifs conserved across many prokaryotic and eukaryotic species. Sequence analyses of C2orf8 excluded coding region mutations as causative of GINGF.   

1.
Aletta JM, Cimato TR, Ettinger MJ: Protein methylation: a signal event in post-translational modification. Trends Biochem Sci 23:89–91 (1998).
2.
Aswad DW: Protein carboxyl methylation in eukaryotes. Curr Opin Cell Biol 1:1182–1187 (1989).
3.
Cheng X: DNA modification by methyltransferases. Curr Opin Struct Biol 5:4–10 (1995).
4.
Gomi T, Tanihara K, Date T, Fujioka M: Rat guanidinoacetate methyltransferase: mutation of amino acids within a common sequence motif of mammalian methyltransferase does not affect catalytic activity but alters proteolytic susceptibility. Int J Biochem. 24:639–1649 (1992).
5.
Gray NK, Wickens M: Control of translation initiation in animals. A Rev Cell Dev Biol 14:399–458 (1998).
6.
Hamahata A, Takata Y, Gomi T, Fujioka M: Probing the S-adenosylmethionine-binding site of rat guanidinoacetate methyltransferase. Effect of site-directed mutagenesis of residues that are conserved across mammalian non-nucleic acid methyltransferases. Biochem J 317:141–145 (1996).
7.
Hart TC, Pallos D, Bowden DW, Bolyard J, Pettenati MJ, Cortelli JR: Genetic linkage of herediary gingival fibromatosis to chromosome 2p21. Am J hum Genet 62:876–883 (1998).
8.
Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG: Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J hum Genet 8:725–729 (2000).
9.
Huo L, Scarpulla RC: Multiple 5′-untranslated exons in the nuclear respiratory factor 1 gene span 47 kb and contribute to transcript heterogeneity and translational efficiency. Gene 233:213–224 (1999).
10.
Jiang H, Lucy MC: Variants of the 5′-untranslated region of the bovine growth hormone receptor mRNA: isolation, expression and effects on translational efficiency. Gene 265:45–53 (2001).
11.
Jitrapakdee S, Booker GW, Cassady AI, Wallace JC: The rat pyruvate carboxylase gene structure. Alternate promoters generate multiple transcripts with the 5′-end heterogeneity. J biol Chem 272:20522–20530 (1997).
12.
Kagan RM, Clarke S: Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes. Arch Biochem Biophys 310:417–427 (1994).
13.
Keaveney M, Parker MG: Gannon F: Identification of a functional role for the 3′ region of the human oestrogen receptor gene. J Mol Endocrinol 10:143–152 (1993).
14.
Lee PT, Hsu AY, Ha HT, Clarke CF: A C-methyltransferase involved in both ubiquinone and menaquinone biosynthesis: isolation and identification of the Escherichia coli ubiE gene. J Bacteriol 179:1748–1754 (1997).
15.
Lewin B: Isolating the gene, in Lewin B (ed): Gene, pp 115–149 (Oxford University Press, New York 1997).
16.
Ogram SA, Reeves R: Differential regulation of a multipromoter gene: selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene. J biol Chem 270:14235–14242 (1995).
17.
Pettenati MJ, Rao PN, Hodge R, Brewer G: Gene mapping by fluorescence in situ hybridization (FISH), in Ross J (ed): Nucleic Acid Hybridization: Essential Techniques, pp 81–109 (John Wiley and Sons, New York 1998).
18.
Ranganathan G, Ong JM, Yukht A, Saghizadeh M, Simsolo RB, Pauer A, Kern PA: Tissue-specific expression of human lipoprotein lipase. Effect of the 3′-untranslated region on translation. J biol Chem 270:7149–7155 (1995).
19.
Reddy KL, Wohlwill A, Dzitoeva S, Lin MH, Holbrook S, Storti RV: The Drosophila PAR domain protein 1 (Pdp1) gene encodes multiple differentially expressed mRNAs and proteins through the use of multiple enhancers and promoters. Dev Biol 224:401–414 (2000).
20.
Shashi V, Pallos D, Pettenati MJ, Cortelli JR, Fryns JP, von Kap-Herr C, Hart TC: Genetic heterogeneity of gingival fibromatosis on chromosome 2? J med Genet 36:683–686 (1999).
21.
Szyf M: The role of DNA methyltransferase 1 in growth control. Front Biosci 6:D599–D609 (2001).
22.
Yang H, Huang ZZ, Zeng Z, Chen C, Selby RR, Lu SC: Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. Am J Physiol Gastrointest Liver Physiol 280:G184–G190 (2001).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.